SCHEMBL3105147

SCHEMBL3105147

Fc1ccc(-c2nn3c(c2-c2ccnc(NC4CCC4)n2)CCNC3)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 2/20 0.60
MAPK8 P45983 3/20 0.49
PRKD3 O94806 2/20 0.49
MAP4K4 O95819 2/20 0.49
MAPK1 P28482 2/20 0.49
MAPK9 P45984 2/20 0.49
CSNK1A1 P48729 2/20 0.49
GSK3A P49840 2/20 0.49
GSK3B P49841 2/20 0.49
CSNK1G2 P78368 2/20 0.49
TAOK1 Q7L7X3 2/20 0.49
MINK1 Q8N4C8 2/20 0.49
PRKD2 Q9BZL6 2/20 0.49
CSNK1G1 Q9HCP0 2/20 0.49
CSNK1G3 Q9Y6M4 2/20 0.49
CLK2 P49760 1/20 0.49
AURKB Q96GD4 1/20 0.49
HIPK2 Q9H2X6 1/20 0.49
PIM2 Q9P1W9 1/20 0.49
ALK Q9UM73 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3108243 0.87 CSNK1D (0.67) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL10290858 0.85 CSNK1D (0.68) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL10290370 0.85 CSNK1D (0.67) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL3113155 0.84 CSNK1D (0.51) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL3112050 0.83 CSNK1D (0.68) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL3107780 0.81 KCNH2 (0.46) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL3107978 0.81 CSNK1D (0.42) CSNK1DPRKD3MAP4K4MAPK1MAPK9
SCHEMBL3107423 0.80 CSNK1D (0.56) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL10290481 0.79 CSNK1D (0.90) CSNK1DMAPK8PRKD3MAP4K4MAPK1
SCHEMBL3100630 0.78 PTGS2 (0.39) CSNK1DMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100273775-A1 FUNGICIDAL BICYCLIC PYRAZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2010-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273775-A1 FUNGICIDAL BICYCLIC PYRAZOLES CYP1B1, CBR1, CYP1A1 CSNK1D 1670/4885MAPK8 2725/4885PRKD3 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.